AU2024337896A1 - Method for selectively producing single axially chiral compound - Google Patents

Method for selectively producing single axially chiral compound

Info

Publication number
AU2024337896A1
AU2024337896A1 AU2024337896A AU2024337896A AU2024337896A1 AU 2024337896 A1 AU2024337896 A1 AU 2024337896A1 AU 2024337896 A AU2024337896 A AU 2024337896A AU 2024337896 A AU2024337896 A AU 2024337896A AU 2024337896 A1 AU2024337896 A1 AU 2024337896A1
Authority
AU
Australia
Prior art keywords
compound
formula
group
salt
chemical formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024337896A
Other languages
English (en)
Inventor
Yuki Hirose
Sunao Imada
Hiroki Ishioka
Kenichi Kawaguchi
Eiji Kawaminami
Junpei OHTAKA
Tomohiro Yoshinari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of AU2024337896A1 publication Critical patent/AU2024337896A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2024337896A 2023-09-08 2024-09-06 Method for selectively producing single axially chiral compound Pending AU2024337896A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2023/032816 WO2025052649A1 (ja) 2023-09-08 2023-09-08 単一の軸不斉化合物の選択的製造法
AUPCT/JP2023/032816 2023-09-08
PCT/JP2024/031959 WO2025053242A1 (ja) 2023-09-08 2024-09-06 単一の軸不斉化合物の選択的製造法

Publications (1)

Publication Number Publication Date
AU2024337896A1 true AU2024337896A1 (en) 2026-03-19

Family

ID=94923286

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2024337896A Pending AU2024337896A1 (en) 2023-09-08 2024-09-06 Method for selectively producing single axially chiral compound

Country Status (6)

Country Link
JP (1) JP7700399B1 (https=)
CN (1) CN121843933A (https=)
AU (1) AU2024337896A1 (https=)
CO (1) CO2026004110A2 (https=)
TW (1) TW202527939A (https=)
WO (2) WO2025052649A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190186A1 (ar) * 2017-02-02 2019-08-01 Astellas Pharma Inc مركب كينازولين
KR20230145361A (ko) * 2021-02-15 2023-10-17 아스텔라스세이야쿠 가부시키가이샤 G12d 변이 kras 단백의 분해를 유도하기 위한 퀴나졸린화합물
AU2022219651A1 (en) * 2021-02-15 2023-09-07 Astellas Pharma Inc. 4-aminoquinazoline compound
AU2023231912A1 (en) * 2022-03-11 2024-08-15 Astellas Pharma Inc. Heterocyclic compound for inducing degradation of g12d mutant kras protein
TW202409002A (zh) * 2022-07-21 2024-03-01 日商安斯泰來製藥股份有限公司 作用於g12d突變kras蛋白之雜環化合物
CN119630656A (zh) * 2022-08-05 2025-03-14 安斯泰来制药株式会社 用于诱导突变kras蛋白分解的杂环化合物
WO2024034593A1 (ja) * 2022-08-09 2024-02-15 アステラス製薬株式会社 G12v変異krasタンパクの分解を誘導するための複素環化合物
TW202412790A (zh) * 2022-08-09 2024-04-01 日商安斯泰來製藥股份有限公司 用於抑制及/或誘導分解kras蛋白之雜環化合物

Also Published As

Publication number Publication date
JP7700399B1 (ja) 2025-06-30
WO2025052649A1 (ja) 2025-03-13
WO2025053242A1 (ja) 2025-03-13
TW202527939A (zh) 2025-07-16
CN121843933A (zh) 2026-04-10
CO2026004110A2 (es) 2026-04-16
JPWO2025053242A1 (https=) 2025-03-13

Similar Documents

Publication Publication Date Title
Zhang et al. Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy
CN110746443B (zh) 一类含有三环杂芳基的化合物
CN101730698B (zh) 用于治疗丙型肝炎的化合物
EP3956320B1 (en) Dihydroorotate dehydrogenase inhibitors
CN119923401A (zh) 新型四杂环化合物
RU2654069C2 (ru) Способ получения тенелиглиптина
CN114929706A (zh) Kras g12c的抑制剂
JP2021502993A (ja) Kras g12c阻害剤
EP2451812A1 (en) SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
MXPA04009318A (es) Derivados de quinolina y su uso como ligados 5-ht6.
WO2016022569A1 (en) Compositions useful for treating disorders related to kit
EP3013835A1 (en) Solid forms of a macrocyclic kinase inhibitor
CN101605798A (zh) 咪唑并噻唑衍生物
CN110041333B (zh) 溴结构域抑制剂化合物及其用途
CN102574860A (zh) 吡咯并[2,3-d]嘧啶化合物
UA126847C2 (uk) Дизаміщені піразольні сполуки як інгібітори кетогексокінази
CN113939518A (zh) 作为激酶抑制剂的稠合三环化合物
JP2009529045A (ja) 7−アルキニル−4−アミノキナゾリンを合成する方法及び関連した中間体
EP3872081A1 (en) Preparation method for deuterated macrocyclic compound
CN114685531A (zh) 四并环化合物及其药物组合物和应用
EP2350079B1 (en) Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes
AU2024337896A1 (en) Method for selectively producing single axially chiral compound
WO2021240429A1 (en) Benzofuran and benzopyran dihydroorotate dehydrogenase inhibitors
CN113527298A (zh) 大环内酰胺类衍生物、及其制备方法和用途
EP4592286A1 (en) Macrocyclic nitrogen-containing crown ether compound and use thereof as protein kinase inhibitor

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ METHOD FOR SELECTIVELY PRODUCING SINGLE AXIALLY CHIRAL COMPOUND